Edwardsiella Tarda Antibody (236/128) [DyLight 650]

• Reactivity: Ba
• Applications: ELISA
• Clone: 236/128
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: DyLight 650

Edwardsiella Tarda Antibody (236/128) [DyLight 650] Summary

• Description: This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.
• Immunogen: Native
• Specificity: This product recognizes Edwardsiella tarda. E. tarda is a member of the family Enterobactericeae associated with freshwater ecosystems that that can cause gastoenteritis, wound infections and death due to septicaemia. It is thought that the pathogenicity of this bacteria is due to it's ability to resist phagocytic killing by the host defences. Studies show that replication of E. tarda in murine macrophages is dependant on the type III secretion system and induces an anti-apoptotic effect by up-regulating anti-apoptotic NF-kB target genes.
• Isotype: IgG1
• Clonality: Monoclonal
• Host: Mouse
• Purity: Protein G purified

Applications/Dilutions

• Dilutions:
  • ELISA
• Application Notes: Optimal dilution of this antibody should be experimentally determined.

Packaging, Storage & Formulations

• Storage: Store at 4C in the dark.
• Buffer: 50mM Sodium Borate
• Preservative: 0.05% Sodium Azide
• Purity: Protein G purified

Notes

DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.

Alternate Names for Edwardsiella Tarda Antibody (236/128) [DyLight 650]

• aracolobactrum anguillimortiferum
• Edwardsiella anguillimortifera

Background

Edwardsiella tarda is a member of the family Enterobactericeae associated with freshwater ecosystems that that can cause gastoenteritis, wound infections and death due to septicaemia. It is thought that the pathogenicity of this bacteria is due to it's ability to resist phagocytic killing by the host defences. Studies show that replication of E. tarda in murine macrophages is dependant on the type III secretion system and induces an anti-apoptotic effect by up-regulating anti-apoptotic NFkB target genes.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.